New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

PBEvsXHEETF Comparison

ETF 1
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-1.96%
VS
ETF 2
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.76%

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. PBE's top 1 sector exposures are Healthcare. In contrast, XHE's top sector exposures are Healthcare and Finance. PBE is more expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.35% for XHE. PBE is up 14.59% year-to-date (YTD) with +$114M in YTD flows. XHE performs worse with 1.67% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of PBE and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBE vs XHE performance and flow charts

Performance

-4.0-2.00.02.04.06.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

0 M20 M40 M60 M80 M100 MAug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/10/2026
1M3MYTD1Y3Y5Y
Perf.
PBE
XHE
-0.70%-4.95%
+12.83%+9.88%
+14.59%+1.67%
+35.63%+11.16%
+57.51%+7.03%
+23.66%-31.12%
Flows
PBE
XHE
+$44M+$5M
+$117M+$14M
+$114M+$13M
+$113M+$2M
+$62M-$264M
+$64M-$380M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBE
XHE
+19.58%+24.14%
+19.33%+22.78%
+20.48%+22.23%
+22.57%+24.84%
Max drawdown
PBE
XHE
-5.73%-7.53%
-11.70%-18.20%
-22.21%-24.35%
-33.32%-49.37%
Max drawdown duration
PBE
XHE
7d22d
166d207d
324d565d
1509d1772d
Trading data

Create an account to view trading data

Join for free
PBE
XHE
Last sale
9/10/2026 at 1:30 PM
$93.03
$89.53
Previous close
09/10/2026
$94.60
$91.41
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PBE
XHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
PBE
XHE
Last price
$93.03
$89.53
1D performance
-1.66%
-2.06%
AuM$405.87 M$170.24 M
E/R0.59%0.35%
Characteristics
PBE
XHE
Management strategyPassivePassive
ProviderInvescoState Street Investment Management
BenchmarkDynamic Biotech & Genome Intellidex IndexS&P Health Care Equipment Select Industry Index
N° of holdings3066
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005January 26, 2011
ESGNoNo
Advertisement
Exposure

Countries

PBE
USA
97.13%
Other
2.87%
XHE
USA
93.56%
Other
6.44%

Sectors

PBE
Healthcare
100%
Other
0%
XHE
Healthcare
98.72%
Other
1.28%
Advertisement

Diversification

PBE

Total weight of top 15 holdings out of 15

61.32%
XHE

Total weight of top 15 holdings out of 15

30.19%

Top 15 holdings

Data as of July 31, 2026
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
XHE
AtriCure, Inc.
2.14%
Glaukos Corp.
2.13%
Dentsply Sirona, Inc.
2.08%
Enovis Corp.
2.07%
Integer Holdings Corp.
2.07%
Butterfly Network, Inc.
2.06%
Neogen Corp.
2.05%
Artivion, Inc.
2.05%
Baxter International, Inc.
2.01%
CONMED Corp.
1.99%
Merit Medical Systems, Inc.
1.98%
QuidelOrtho Corp.
1.94%
ICU Medical, Inc.
1.88%
Tandem Diabetes Care, Inc.
1.88%
Inspire Medical Systems, Inc.
1.85%
Frequently asked questions about PBE and XHE

How have the PBE and XHE ETFs performed in 2026?

As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while XHE has returned 1.67%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or XHE?

Year-to-date, the PBE ETF saw +$114M in flows, compared to +$13M for XHE.

Which ETF is more volatile: PBE or XHE?

Over the past year, PBE had a volatility of 19.33%, while XHE experienced 22.78%.

Which ETF is bigger: PBE or XHE?

As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while XHE manages $170.24 M.

What sectors do the PBE and XHE ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, XHE focuses on Healthcare.

What are the top holdings of the PBE ETF and XHE ETF?

PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. XHE holds in its top three: AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc..

Which ETF is more diversified: PBE or XHE?

PBE holds 30 securities with 61.32% of its assets in the top 15. XHE has 66 securities and a top 15 weight of 30.19%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder